Journal article
Endovascular Advances for Intracranial Occlusive Disease
Neurosurgery, v 74(suppl_1), pp S126-S132
01 Feb 2014
PMID: 24402481
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Abstract
Stroke is the fourth leading cause of death in the United States. Intracranial atherosclerotic disease accounts for 8%-10% of ischemic stroke in the United States. So far, surgical bypass has not proved to be superior to medical therapy. As both medical and endovascular therapies for intracranial atherosclerosis evolve, so too do the guidelines for treatment. Initial reports on the results of stent placement for symptomatic high-grade intracranial atherosclerotic disease were encouraging; however, recent trials suggest that initial medical management may be preferable. Currently, intracranial angioplasty and stenting for symptomatic intracranial atherosclerosis is now more controversial. Further trials are necessary to help determine which patients are ideal for endovascular therapies.
Metrics
Details
- Title
- Endovascular Advances for Intracranial Occlusive Disease
- Creators
- Mandy J. Binning - Capital HealthErol Veznedaroglu - Capital Health
- Publication Details
- Neurosurgery, v 74(suppl_1), pp S126-S132
- Publisher
- Oxford University Press
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Neurology; Neurosurgery
- Web of Science ID
- WOS:000339059800015
- Scopus ID
- 2-s2.0-84892915486
- Other Identifier
- 991021918097104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Clinical Neurology
- Surgery